Please enable Javascript
Ronan Kelly, MD
Articles by Ronan Kelly, MD
LAG-3 and PD-1 Inhibitors for Esophageal and Gastroesophageal Junction Cancer: A Phase Ib Trial
Ronan Kelly, MD
Gastroesophageal Cancer
|
March 13, 2025
Dr. Ronan Kelly describes his trial on nivolumab with relatlimab for the treatment of resectable esophageal/GEJ cancer.
View More